-
Swedish police identify 17-year-old girl as victim in school sword attack
-
Yamaguchi to face An in hunt for fourth badminton world crown
-
Carrick keeps calm despite Man Utd misery, Sage beaten in first game as Palace boss
-
Norris clinches pole for Dutch GP
-
France to deliver interceptor missiles to Ukraine after new Russian strikes
-
Norris clinches pole for Dutch Grand Prix
-
Serena Williams and Alcaraz unite in US Open mixed doubles
-
Pope Leo calls for courage in Rimini visit after stop in tiny San Marino
-
Macron pledges air defence as 13 killed in Russia, Ukraine strikes
-
Man Utd must learn from 'frustrating' defeat at Hull: Carrick
-
DR Congo capital wary of Ebola nightmare
-
Yamaguchi on course for fourth badminton world crown
-
Swedish police name 17-year-old girl as victim in school sword attack
-
Man Utd humiliated by Hull in dismal start to Premier League season
-
South Korea sends first container ship through Arctic route
-
Anthropic market debut could break SpaceX IPO record: media
-
Trescothick eager to keep England job despite Hussey approach
-
Pope's 'couturier of the sacred' fueled by faith
-
Indonesia deploys hundreds of soldiers to tackle Borneo fires
-
Duplantis locked in on 'grinding' for big bars
-
The last lap: Fans, drivers bid fond farewell to Dutch GP
-
Stokes says decision to leave Headingley off Ashes roster 'shambolic'
-
Silesia Diamond League: four events to watch
-
New arrival Rodri to miss Elche opener: Barca's Flick
-
Russell wins Dutch GP sprint race, Antonelli fourth
-
Atletico's Alvarez to return against Villarreal: Simeone
-
Mercedes driver George Russell wins Dutch GP sprint race
-
Dozens of civilians killed, kidnapped as jihadists clash in Nigeria
-
Ukraine strikes kill two children after Russia's deadly mall attack
-
Former envoys urge joint French, UK action on Palestinian territories
-
Pope visits San Marino, before addressing Italian political gathering
-
Australia lead by 101 in 2nd Bangladesh Test as 18 wickets fall on day one
-
Trump tariffs heap up as Canada tries to curb US reliance
-
'Aura' battles leap from social media to Latin America streets
-
Australia lose three wickets after skittling Bangladesh for 64
-
US, Canada fail to reach trade pact to avert Trump tariffs
-
Bangladesh all out for 64 in 2nd Test after Starc masterclass
-
Sudan farms lie barren as El Nino leaves Nile banks dry
-
Odyssey effect: stars sell Greece to a new wave of US tourists
-
Arctic shipping a daunting prospect in hotly contested region
-
South Korea to send first container ship through Arctic route
-
In US, rare earths extracted from coal mine wastewater
-
Starc takes 5-11 to leave Bangladesh reeling in 2nd Test
-
Nakashima pounds Fritz, Bejlek beats Keys in Cincinnati upsets
-
Injured Rune withdraws from US Open
-
Canadian negotiator says 'more work to do' on US trade deal
-
New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET
-
Nakashima knocks out Fritz to reach Cincinnati semi-finals
-
'Solid' Clark takes solo lead at BMW Championship
-
Ukraine says 'cynical' Russian strike on shopping centre killed 16
Social media fuels surge in UK men seeking testosterone jabs
Social media claims by clinics promoting testosterone treatment for men to improve their physique and mood are driving large numbers to pay for unnecessary medication that can have serious side effects, doctors say.
Men's hormone levels can fluctuate for lifestyle reasons but many are being prescribed testosterone replacement therapy (TRT) without medical need despite the health risks, doctors in the UK and Australia told AFP.
Promotional campaigns by private clinics use social media and influencers, as well as an ad campaign in the London Underground, to encourage young body-conscious men to test their levels, claiming fatigue or irritation are symptoms.
"Do you wish you could have more energy? Less body fat? A higher sex drive?" asks one ad.
Costly treatments could be the answer.
The trend is now affecting the state-funded National Health Service, since many seek free treatment there.
The number of men referred to NHS specialists after being diagnosed privately "has really exploded", said Channa Jayasena, a professor of endocrinology at Imperial College.
"It's a huge problem for us, which is impacting our ability to treat other patients."
TRT is needed by those with true deficiency, known as hypogonadism, including men who never went through puberty or had testicular cancer.
But some clinics prescribe it to men with normal levels and risking side-effects including infertility and thickened blood that carries cardiovascular risks, doctors warn.
While private clinics are not obliged to disclose numbers, Jayasena estimated "hundreds of thousands" of men in the UK have accessed costly TRT privately.
And most "just don't need it at all", he said.
- Manosphere -
Isobelle Smith, an endocrinologist in New South Wales, Australia, has made Instagram videos debunking TRT claims.
"I've seen the advertising that up to one in four or one in five men before the age of 40 have testosterone deficiency -- that is just absolutely not true," she told AFP.
"These companies are saying that essentially normal levels are low," she said.
"Really, it's performance-enhancing drugs."
Some link the TRT craze to the "manosphere" culture with its fixation on bulging muscles and longevity.
Misogynist influencer Andrew Tate claims to have "high T" and berates men with "low T". US Health Secretary Robert F. Kennedy Jr. recently extolled President Donald Trump's high levels.
Data on private clinics is not available, but prescriptions for testosterone by family doctors rose 13 percent in 2024 in England, according to the Care Quality Commission regulator.
The NHS in England spent over £30 million ($40.1 million) in 2024 on testosterone jabs and gels, according to the OpenPrescribing website. Some were used for gender change and women's health.
Studies in the United States and Europe have shown testosterone levels declining for decades, which scientists link to lifestyle and environmental factors.
Despite the scepticism from medical professionals, men told AFP they had felt the positive effects of TRT.
Gavin McNamee, a 41-year-old personal trainer from northeast England, said he had had poor mental health and low energy. But after five months of treatment, he said: "I just feel so much better".
"I feel like a different person," agreed Carl Graham, a 38-year-old legal administrator from Liverpool on TRT for over six months.
Neither man consulted NHS doctors, and both inject testosterone prescribed privately, paying £100 to £200 a month.
- 'Take a test' -
Heavily-muscled influencers promote clinics offering TRT via gels, pills or injections.
Jayasena said images of "men with six-packs even in their 50s and 60s", such as Amazon founder Jeff Bezos, had great sway.
Advertising testosterone, like any prescription-only medicine, is illegal in the UK.
But private clinics circumvent this by advertising blood tests.
"Feeling tired, unfocused, or taking longer to recover after workouts? It could be time to check your testosterone levels," reads one ad for Harley Street TRT provider.
"If you don't feel like you're firing on all cylinders, take a test," ex-commando and television personality Jason Fox says in a video promoted by online provider Voy.
The ads appear to target young men, and Harley Street TRT has a "25 plus" setting on its Meta ads, offering personal trainers £50 per referral.
Each patient generates an "average £1,500 ($2,000) profit per year," it says.
L.Adams--AT